HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Jankowski, M Articles by Gutkowska, J Search for Related Content PubMed PubMed Citation Articles by Jankowski, M Articles by Gutkowska, J

Laboratory of Cardiovascular Biochemistry, Centre de recherche, Centre hospitalier de l’Université de Montreal (CHUM) Montreal, Quebec, Canada

(Requests for offprints should be addressed to Marek Jankowski, Centre de recherche du CHUM-Hôtel-Dieu, Pavillon de Bullion (6-816), 3840 rue Saint-Urbain, Montreal, Quebec, Canada, H2W 1T8; Email: marek.jankowski{at}umontreal.ca)

Cyclic guanosine monophosphate (cGMP), which is implicated in cardiac cell growth and function, is synthesized by cytoplasmic soluble guanylyl cyclase (GC) stimulated via nitric oxide (NO) and by particulate membrane-bound GC activated via natriuretic peptides. We investigated possible cGMP elevation in the left ventricle (LV) of rats developing physiologic LV hypertrophy during gestation. Furthermore, expression of estrogen receptors (ER) and oxytocin receptors (OTR) was evaluated because their activation stimulates NO and atrial natriuretic peptide (ANP) release from the heart. Compared with nonpregnant controls, Sprague-Dawley rats on day 7 of gestation had similar heart weights, but, on days 14 and 21, ventricular mass increased by 12% and 28% respectively (P< 0.05). LV cGMP concentration was elevated at day 14 of gestation (3.25 ± 0.12 vs 4.65 ± 0.17 pmol/g wet weight, P< 0.01) but decreased at day 21 (2.45 ± 0.09 pmol/g, P< 0.05) to increase again on postpartum day 1 (6.01 ± 0.15 pmol/g) and day 4 (9.21 ± 1.79 pmol/g). Changes in endothelial nitric oxide synthase (eNOS), inducible NOS (iNOS), OTR and ER, but not ERß, proteins paralleled the pregnancy-related cGMP changes in the LV. In contrast, ANP mRNA of the LV remained at control level throughout gestation but increased postpartum, whereas brain natriuretic peptide (BNP) expression declined at term and increased postpartum. The particulate GC natriuretic peptide receptors (GC-A and GC-B) transcripts were already lower at day 14 of gestation. Natriuretic peptide clearance receptor (NPR-C) transcript was not altered on days 7 and 14, but increased at term. We conclude that cGMP concentration in the rat LV is influenced by both NOS and natriuretic peptide systems and may be involved in the changes of LV contractility and hypertrophy that occur during rat gestation.

This article has been cited by other articles:

				A. M. D. Gonzalez, J. C. Osorio, C. Manlhiot, D. Gruber, S. Homma, and S. Mital Hypertrophy signaling during peripartum cardiac remodeling Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3008 - H3013. [Abstract] [Full Text] [PDF]

				J. Gutkowska, A. Paquette, D. Wang, J.-M. Lavoie, and M. Jankowski Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R267 - R275. [Abstract] [Full Text] [PDF]

				B. A. Danalache, J. Paquin, W. Donghao, R. Grygorczyk, J. C. Moore, C. L. Mummery, J. Gutkowska, and M. Jankowski Nitric Oxide Signaling in Oxytocin-Mediated Cardiomyogenesis Stem Cells, March 1, 2007; 25(3): 679 - 688. [Abstract] [Full Text] [PDF]

				A. Lev-Sagie, B. Bar-Oz, L. Salpeter, D. Hochner-Celnikier, I. Arad, and A. Nir Plasma Concentrations of N-Terminal Pro-B-Type Natriuretic Peptide in Pregnant Women near Labor and during Early Puerperium Clin. Chem., October 1, 2005; 51(10): 1909 - 1910. [Full Text] [PDF]